Shares of Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) were up 3.3% during mid-day trading on Wednesday . The company traded as high as $39.48 and last traded at $39.14. Approximately 2,798 shares traded hands during trading, a decline of 98% from the average daily volume of 160,858 shares. The stock had previously closed at $37.89.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on ASTH shares. Truist Financial upped their price target on shares of Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a report on Friday, March 1st. Jefferies Financial Group initiated coverage on shares of Astrana Health in a research note on Monday, February 26th. They issued a “buy” rating and a $50.00 target price for the company.
Get Our Latest Stock Analysis on Astrana Health
Astrana Health Price Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.09. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm had revenue of $353.00 million during the quarter, compared to analyst estimates of $341.17 million. During the same quarter in the prior year, the business posted $0.02 earnings per share. The company’s quarterly revenue was up 20.0% compared to the same quarter last year. Analysts expect that Astrana Health, Inc. will post 1.62 EPS for the current fiscal year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Read More
- Five stocks we like better than Astrana Health
- How to Use the MarketBeat Stock Screener
- Comprehensive PepsiCo Stock Analysis
- How to Invest in Insurance Companies: A GuideĀ
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Where Do I Find 52-Week Highs and Lows?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.